1 February 2023 - Del. Rasoul is proposing Virginia create an independent panel of health care experts to review drug price ...
2 February 2023 - Restrained increases come as US implements the Inflation Reduction Act. ...
2 February 2023 - In an environment where gastric cancer treatments are currently lacking, the approval of Enhertu (ingredient: trastuzumab ...
1 February 2023 - Medexus Pharmaceuticals wishes to inform investors that the company has reached an agreement with the provincial government ...
2 February 2023 - First and only respiratory biologic without phenotype or biomarker limitations that offers the choice of administration ...
2 February 2023 - New results from an early-initiated study show advantages in overall survival. ...
2 February 2023 - Calliditas Therapeutics today announced that the MHRA of the United Kingdom has granted conditional marketing authorisation for ...
2 February 2023 - Today, Professor John Skerritt has announced his decision to retire from his position of Deputy Secretary ...
1 February 2023 - Today, the US FDA approved Jesduvroq tablets (daprodustat) as the first oral treatment for anaemia caused by ...
31 January 2023 - FLAG Therapeutics announced today that FLAG-003, an investigational small molecule therapy for the treatment of diffuse intrinsic ...
30 January 2023 - Collaboration focuses on pricing transparency, affordable access, and engaging patients at home to ensure treatment adherence. ...
31 January 2023 - The retail price of Simcere Pharmaceutical’s orally taken COVID-19 treatment, which was only approved to go ...
1 February 2023 - Nintedanib esylate is recommended as an option for the treatment of adults with idiopathic pulmonary fibrosis ...
1 February 2023 - These fee increases are an important step to ensuring the MHRA has the resources it needs ...
1 February 2023 - Somatrogon is recommended as an option for the treatment of children 3 years of age and over ...